[go: up one dir, main page]

DK1583967T3 - Fremgangsmåde til inhibering af replikationen af herpesvira - Google Patents

Fremgangsmåde til inhibering af replikationen af herpesvira

Info

Publication number
DK1583967T3
DK1583967T3 DK03795968T DK03795968T DK1583967T3 DK 1583967 T3 DK1583967 T3 DK 1583967T3 DK 03795968 T DK03795968 T DK 03795968T DK 03795968 T DK03795968 T DK 03795968T DK 1583967 T3 DK1583967 T3 DK 1583967T3
Authority
DK
Denmark
Prior art keywords
replication
inhibiting
herpes viruses
herpesviruses
methods
Prior art date
Application number
DK03795968T
Other languages
Danish (da)
English (en)
Inventor
Ulrich Betz
Guy Hewlett
Gerald Kleymann
Thomas Lampe
Susanne Nikolic
Juergen Reefschlaeger
Tobias Wunberg
Holger Zimmermann
Kerstin Henninger
Axel Jensen
Joerg Keldenich
Rudolf Schohe-Loop
Tse-I Lin
Franz Zumpe
Wolfgang Bender
Original Assignee
Aicuris Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aicuris Gmbh & Co Kg filed Critical Aicuris Gmbh & Co Kg
Application granted granted Critical
Publication of DK1583967T3 publication Critical patent/DK1583967T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/40Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56994Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK03795968T 2003-01-07 2003-12-24 Fremgangsmåde til inhibering af replikationen af herpesvira DK1583967T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10300109A DE10300109A1 (de) 2003-01-07 2003-01-07 Methode zur Inhibition der Replikation von Herpesviren
PCT/EP2003/014883 WO2004060860A2 (fr) 2003-01-07 2003-12-24 Procede pour inhiber la replication de virus herpetiques

Publications (1)

Publication Number Publication Date
DK1583967T3 true DK1583967T3 (da) 2007-08-06

Family

ID=32519615

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03795968T DK1583967T3 (da) 2003-01-07 2003-12-24 Fremgangsmåde til inhibering af replikationen af herpesvira

Country Status (9)

Country Link
US (1) US20070004735A1 (fr)
EP (1) EP1583967B1 (fr)
AT (1) ATE365920T1 (fr)
AU (1) AU2003298244A1 (fr)
DE (2) DE10300109A1 (fr)
DK (1) DK1583967T3 (fr)
ES (1) ES2286499T3 (fr)
PT (1) PT1583967E (fr)
WO (1) WO2004060860A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10590094B2 (en) 2016-04-06 2020-03-17 Innovative Molecules Gmbh Aminothiazole derivatives useful as antiviral agents
UA126163C2 (uk) 2017-10-05 2022-08-25 Інновейтів Молекьюлз Ґмбх Енантіомери серії противірусних сполук

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU659861B2 (en) * 1991-09-10 1995-06-01 Sansho Seiyaku Co., Ltd. Preparation for promoting hair growth
US6054472A (en) * 1996-04-23 2000-04-25 Vertex Pharmaceuticals, Incorporated Inhibitors of IMPDH enzyme
CA2223032A1 (fr) * 1997-02-21 1998-08-21 Smithkline Beecham Corporation Utilisation de ul-15 et de vp5 du hsv-1 pour la detection d'agents antiviraux
WO2000009158A1 (fr) * 1998-08-12 2000-02-24 University Of Virginia Patent Foundation Essai pour l'assemblage de la capside du virus de l'herpes simplex
US20010007877A1 (en) * 1998-12-16 2001-07-12 George O. Burton Novel anti-infectives
DE10148598A1 (de) * 2001-04-19 2002-10-24 Bayer Ag Neue Arylsulfonamide als antivirale Mittel
DE10131133A1 (de) * 2001-06-28 2003-01-16 Bayer Ag Pyridazinone
DE10222024A1 (de) * 2002-05-17 2003-11-27 Bayer Ag Lactame

Also Published As

Publication number Publication date
AU2003298244A1 (en) 2004-07-29
AU2003298244A8 (en) 2004-07-29
DE50307587D1 (de) 2007-08-09
ATE365920T1 (de) 2007-07-15
WO2004060860A2 (fr) 2004-07-22
US20070004735A1 (en) 2007-01-04
DE10300109A1 (de) 2004-07-15
PT1583967E (pt) 2007-07-13
EP1583967A2 (fr) 2005-10-12
ES2286499T3 (es) 2007-12-01
WO2004060860A3 (fr) 2005-02-10
EP1583967B1 (fr) 2007-06-27

Similar Documents

Publication Publication Date Title
DK1716162T3 (da) Phosphonater, amidomonophosphonater, amidobisphosphonater til behandling af virussygdomme
DK1656372T3 (da) 2,4-pyrimidindiaminforbindelser til anvendelse til behandling eller forebyggelse af autoimmunsygdomme
BRPI0411900B8 (pt) compostos e composições farmacêuticas compreendendo os mesmos
BRPI0410870A (pt) compostos trieterocìclicos, composições, e métodos para tratar cáncer ou doenças virais
NO20085373L (no) P38 inhibitorer, deres fremstilling og anvendelse
WO2004085479A3 (fr) Traitement d'infections virales
WO2008127364A3 (fr) Composés antiviraux et utilisation de ceux-ci
DK1519724T3 (da) Fredericamycin-derivater som lægemidler til behandling af tumorer
MY140826A (en) Substituted pyrazoline compounds, their preparation and use as medicaments.
BR0309581A (pt) Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c
EA201200631A1 (ru) Ингибиторы репликации вируса иммунодефицита человека
BRPI0507628A (pt) composto ou sal farmaceuticamente aceitável do mesmo, método de tratamento de uma infecção viral em um ser humano, uso de um composto composição farmacêutica, e, processo para a preparação de um composto
NO20083002L (no) Fremgangsmate for anvendelse av CD40-bindende forbindelser
BRPI0516483A (pt) preparo e uso de derivados de ácido bifenil-4-il-carbonilamino para o tratamento de obesidade
DOP2010000304A (es) Composiciones y metodos de preparacion y uso de las mismas
CY1106386T1 (el) Υποκατεστημενα παραγωγα 3-πυρρολιδιν-ινδολης
BRPI0412999A (pt) 2-aminotetralina substituìda para tratamento de depressão
AP2150A (en) Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication.
BRPI0416287A (pt) compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que são moduladas por inibidores de accß e sua utilização
NO20091955L (no) Antivirale sammensetninger, og fremgangsmater for anvendelse
BRPI0514133A (pt) compostos de fórmula i, processo para a sua fabricação, composições farmacêuticas, método para o tratamento e/ou profilaxia de doença que são mediadas por inibidores de cetp e uso dos compostos de fórmula i
MX2009011512A (es) Nuevos compuestos peptidos ciclicos.
BRPI0920605A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, método para o tratamento ou profilaxia de infecção pelo hiv ou para o tratamento, profilaxia, ou retardo no início ou progressão da aids em um paciente em necessidade deste.
BRPI0513513A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, processo para preparar o mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, métodos para produzir um efeito inibitório de eg5 e um efeito anticáncer em um animal de sangue quente, e para tratar carcinomas em um animal de sangue quente
DK1614419T3 (da) Midler til forebyggelse/behandling af retinale nervesygdomme, indeholdende alkyletherderivater eller salte deraf